Zoltán Szekanecz

Q: What Schools Are Affiliated With Zoltán Szekanecz

Zoltán Szekanecz is affiliated with the following schools: University of Oslo, University of Debrecen

Zoltán Szekanecz's AcademicInfluence.com Rankings

Zoltán Szekanecz

Philosophy

#8273

World Rank

#11620

Historical Rank

Logic

#5309

World Rank

#6698

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Zoltán Szekanecz's Degrees

PhD Rheumatology University of Debrecen
Doctorate Medicine University of Debrecen

Why Is Zoltán Szekanecz Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Zoltán Szekanecz's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis (2009) (1304)
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update (2016) (865)
2016 update of the EULAR recommendations for the management of early arthritis (2016) (375)
Macrophages and their products in rheumatoid arthritis (2007) (316)
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? (2010) (306)
Vitamin D and autoimmune thyroid diseases (2011) (276)
Genetics of Rheumatoid Arthritis — A Comprehensive Review (2013) (268)
Chemokines and chemokine receptors in rheumatoid arthritis. (2003) (260)
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment (2014) (253)
2018 update of the EULAR recommendations for the management of hand osteoarthritis (2018) (220)
Novel Biomarkers in Autoimmune Diseases (2007) (198)
Association of systemic and thyroid autoimmune diseases (2006) (194)
Mechanisms of Disease: angiogenesis in inflammatory diseases (2007) (193)
Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity. (2008) (191)
Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. (2010) (188)
Vascular involvement in rheumatic diseases: 'vascular rheumatology' (2008) (174)
Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. (2000) (174)
Rheumatoid arthritis and metabolic syndrome (2014) (170)
In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. (1993) (167)
Chemokines and angiogenesis (2001) (150)
Angiogenesis and vasculogenesis in rheumatoid arthritis (2010) (143)
Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis (2007) (140)
Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications. (2007) (139)
Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). (2003) (139)
Chemokines and chemokine receptors in arthritis. (2010) (137)
Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis (2009) (135)
Validated methods for assessment of subclinical atherosclerosis in rheumatology (2012) (135)
Cytokines in Rheumatoid Arthritis (1995) (133)
Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). (2005) (133)
Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. (2011) (128)
Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. (1994) (126)
Survival and causes of death in 366 Hungarian patients with systemic sclerosis (2007) (126)
Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases (2002) (122)
EULAR definition of difficult-to-treat rheumatoid arthritis (2020) (114)
A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima–media in patients with systemic autoimmune diseases (2009) (111)
Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment. (2011) (110)
Assessment of Subclinical Vascular Disease Associated with Ankylosing Spondylitis (2011) (107)
TLRs, future potential therapeutic targets for RA. (2017) (105)
Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice (2007) (105)
Successes and failures of chemokine-pathway targeting in rheumatoid arthritis (2016) (103)
Evaluation of Tear Osmolarity in Non-Sjögren and Sjögren Syndrome Dry Eye Patients With the TearLab System (2012) (102)
Angiogenesis and its targeting in rheumatoid arthritis. (2009) (101)
Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets (2010) (100)
The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis. (1999) (100)
Accelerated Atherosclerosis in Rheumatoid Arthritis (2005) (100)
Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: The possible role for IL-6 and interferon-gamma in vascular inflammation (1994) (99)
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges (2017) (92)
Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis. (2007) (91)
Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis: As Good as it Gets? (2008) (90)
B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives. (2011) (88)
Vascular effects of biologic agents in RA and spondyloarthropathies (2009) (83)
Targeting of proangiogenic signalling pathways in chronic inflammation (2016) (83)
Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance. (1998) (82)
Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. The possible role of these cytokines in human aortic aneurysmal blood vessel growth. (1994) (80)
New insights in synovial angiogenesis. (2010) (78)
Antiphospholipid antibodies in acute coronary syndrome (2003) (77)
Chemokines in rheumatic diseases. (2006) (77)
Increased synovial expression of transforming growth factor (TGF)-beta receptor endoglin and TGF-beta 1 in rheumatoid arthritis: possible interactions in the pathogenesis of the disease. (1995) (76)
Vascular endothelium and immune responses: implications for inflammation and angiogenesis. (2004) (74)
Clinical Course, Prognosis, and Causes of Death in Mixed Connective Tissue Disease (2013) (72)
Malignancies and soluble tumor antigens in rheumatic diseases. (2006) (72)
Angiogenesis in rheumatoid arthritis. (2005) (70)
Antigen-specific immunotherapies in rheumatic diseases (2017) (69)
Chemokines and angiogenesis in rheumatoid arthritis. (2009) (67)
Preclinical and clinical investigation of a CCR5 antagonist, AZD5672, in patients with rheumatoid arthritis receiving methotrexate. (2010) (65)
Cellular adhesion molecules in rat adjuvant arthritis. (1996) (63)
Malignancies in Autoimmune Rheumatic Diseases – A Mini-Review (2010) (63)
Disturbances in B- and T-cell homeostasis in rheumatoid arthritis: suggested relationships with antigen-driven immune responses. (2007) (62)
EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases (2019) (62)
Cellular adhesion molecules in rheumatoid arthritis: regulation by cytokines and possible clinical importance. (1996) (62)
Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope. (2008) (60)
Balneotherapy in elderly patients: effect on pain from degenerative knee and spine conditions and on quality of life. (2008) (60)
Intercellular adhesion molecule‐1 (ICAM‐1) expression and soluble ICAM‐1 (sICAM‐1) production by cytokine‐activated human aortic endothelial cells: a possible role for ICAM‐1 and sICAM‐1 in atherosclerotic aortic aneurysms (1994) (60)
Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. (2008) (58)
Association of ARTS1 Gene Polymorphisms with Ankylosing Spondylitis in the Hungarian Population: The rs27044 Variant Is Associated with HLA-B*2705 Subtype in Hungarian Patients with Ankylosing Spondylitis (2010) (58)
Of mice and men: how animal models advance our understanding of T-cell function in RA (2014) (58)
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey (2018) (58)
Biopharmaceuticals for rheumatic diseases in Latin America, Europe, Russia, and India: innovators, biosimilars, and intended copies. (2014) (57)
Cardiac manifestations in antiphospholipid syndrome. (2007) (57)
Therapeutic inhibition of leukocyte recruitment in inflammatory diseases. (2004) (56)
Update on synovitis (2001) (56)
Cell-cell interactions in synovitis: Endothelial cells and immune cell migration (2000) (56)
Prolactin and Autoimmunity (2012) (56)
Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity. (2007) (54)
Malignancies associated with systemic sclerosis. (2012) (52)
Effects of Biologics on Vascular Function and Atherosclerosis Associated with Rheumatoid Arthritis (2009) (52)
Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis (2006) (51)
Association of Rheumatoid Arthritis with HLA‐DR1 and HLA‐DR4 in Hungary (2005) (51)
Angiogenesis in rheumatoid arthritis (2009) (51)
Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases (2021) (51)
Evaluation of commonly used tear sampling methods and their relevance in subsequent biochemical analysis (2017) (50)
Oxidative stress impairs energy metabolism in primary cells and synovial tissue of patients with rheumatoid arthritis (2018) (50)
The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout. (2019) (50)
Effects of targeted therapies on the bone in arthritides. (2017) (49)
Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do. (2016) (48)
Increased Production of the Soluble Tumor‐Associated Antigens CA19‐9, CA125, and CA15‐3 in Rheumatoid Arthritis (2007) (47)
Relationship Between Rheumatoid Factor Isotypes and IgG Anti-Cyclic Citrullinated Peptide Antibodies (2010) (46)
Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis. (2011) (45)
Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms. (2004) (45)
Elevated Levels of Anti-Helicobacter pylori Antibodies in Henoch–Schönlein Purpura (2003) (43)
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome (2022) (43)
Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices. (2008) (43)
Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis - a prospective case-series study (2013) (39)
Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease (2013) (39)
Impact of obesity on autoimmune arthritis and its cardiovascular complications. (2018) (39)
Pro-inflammatory cytokines in atherosclerosis. (2008) (39)
Increased synovial expression of the adhesion molecules CD66a, CD66b, and CD31 in rheumatoid and osteoarthritis. (1995) (38)
Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases. (2011) (38)
Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis (2019) (38)
Ferritin and prolactin levels in multiple sclerosis. (2011) (37)
Cardiovascular effects of approved drugs for rheumatoid arthritis (2021) (37)
Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome (2011) (37)
Hyperferritinemia is Associated with Serologic Antiphospholipid Syndrome in SLE Patients (2013) (36)
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis (2021) (36)
Transmembrane TNF-α Reverse Signaling Inhibits Lipopolysaccharide-Induced Proinflammatory Cytokine Formation in Macrophages by Inducing TGF-β: Therapeutic Implications (2016) (36)
Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis. (2008) (36)
Endothelial cells in inflammation and angiogenesis. (2005) (36)
Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters. (2011) (35)
Costs of rheumatoid arthritis in Hungary. (2007) (35)
Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: a pilot study (2014) (35)
Biologics - beyond the joints. (2010) (34)
Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept. (2016) (34)
Plasma Homocysteine Levels, The Prevalence of Methylenetetrahydrofolate Reductase Gene C677T Polymorphism and Macrovascular Disorders in Systemic Sclerosis: Risk Factors for Accelerated Macrovascular Damage? (2009) (34)
Effects of thrombospondin-1 on disease course and angiogenesis in rat adjuvant-induced arthritis. (1998) (34)
Intracytoplasmic Cytokine Expression and T Cell Subset Distribution in the Peripheral Blood of Patients with Ankylosing Spondylitis (2008) (33)
Combined plasmapheresis and high-dose intravenous immunoglobulin treatment in systemic sclerosis for 12 months: follow-up of immunopathological and clinical effects (2008) (33)
Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects (2009) (33)
Suppression of Proteoglycan-Induced Autoimmune Arthritis by Myeloid-Derived Suppressor Cells Generated In Vitro from Murine Bone Marrow (2014) (32)
Improvement in pain intensity, spine stiffness, and mobility during a controlled individualized physiotherapy program in ankylosing spondylitis (2012) (32)
The genetic background of ankylosing spondylitis. (2009) (32)
Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population (2013) (32)
Anti-mutated citrullinated vimentin (anti-MCV) and anti-65 kDa heat shock protein (anti-hsp65): new biomarkers in ankylosing spondylitis. (2012) (31)
Otosclerosis: an autoimmune disease? (2009) (31)
New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies. (2010) (31)
Accelerated atherosclerosis in rheumatoid arthritis. (2007) (31)
Gastrointestinal manifestations in Hungarian scleroderma patients (2006) (31)
Lymphocyte adhesion to high endothelium is mediated by two beta 1 integrin receptors for fibronectin, alpha 4 beta 1 and alpha 5 beta 1. (1992) (31)
Common mechanisms and holistic care in atherosclerosis and osteoporosis (2019) (30)
Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison (2014) (30)
Lupus and Cardiovascular Disease: The Facts (2006) (30)
Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease. (2002) (29)
Perspectives of pharmacological treatment in otosclerosis (2013) (28)
Longterm Effects of Rituximab on B Cell Counts and Autoantibody Production in Rheumatoid Arthritis: Use of High-sensitivity Flow Cytometry for More Sensitive Assessment of B Cell Depletion (2013) (27)
Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis (2014) (27)
Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis (2008) (27)
Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis (2019) (26)
Homozygosity for the 168His variant of the minor histocompatibility antigen HA‐1 is associated with reduced risk of primary Sjögren's syndrome (2005) (26)
Development of temporomandibular joint arthritis: The use of animal models. (2017) (25)
Pharmacogenetics and pharmacogenomics in rheumatology (2013) (25)
Microbiological Profile of Adenoid Hypertrophy Correlates to Clinical Diagnosis in Children (2013) (25)
Targeting Angiogenesis in Rheumatoid Arthritis. (2008) (24)
Peripheral Blood Gene Expression and IgG Glycosylation Profiles as Markers of Tocilizumab Treatment in Rheumatoid Arthritis (2012) (24)
Catastrophic antiphospholipid syndrome in cancer. (2000) (22)
Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues. (1997) (22)
Differentially expressed epigenome modifiers, including aurora kinases A and B, in immune cells in rheumatoid arthritis in humans and mouse models. (2013) (21)
Genetic control of experimental spondylarthropathy. (2005) (20)
Leukocyte-endothelial adhesion molecules in the rheumatoid synovium (2004) (20)
Patients’ access to biological therapy in chronic inflammatory conditions; per capita GDP does not explain the intercountry differences (2016) (19)
Association of ANCA-associated vasculitis-rheumatoid arthritis overlap syndrome in four patients: Rituximab may be the right choice? (2012) (18)
Pneumococcal vaccination in autoimmune rheumatic diseases (2017) (18)
Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis (2017) (18)
Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis (2021) (18)
Endothelial progenitor cells in arthritis-associated vasculogenesis and atherosclerosis. (2009) (17)
EULAR ‘points to consider’ for the conduction of workforce requirement studies in rheumatology (2018) (17)
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial (2022) (17)
Follicular helper T cells in autoimmune diseases. (2014) (17)
Marked diversity of IL23R gene haplotype variants in rheumatoid arthritis comparing with Crohn’s disease and ankylosing spondylitis (2012) (17)
Induction of response with etanercept–methotrexate therapy in patients with moderately active rheumatoid arthritis in Central and Eastern Europe in the PRESERVE study (2013) (16)
A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis (2019) (16)
Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study) (2022) (16)
HLA-DR genotypes in familial rheumatoid arthritis: increased frequency of protective and neutral alleles in a multicase family. (2005) (16)
Biologics, cardiovascular effects and cancer (2014) (16)
Vascular Endothelial Growth Factor in Tear Samples of Patients with Systemic Sclerosis (2015) (16)
Cognitive dysfunction in autoimmune rheumatic diseases (2020) (16)
Derailed B cell homeostasis in patients with mixed connective tissue disease. (2013) (16)
Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis (2019) (15)
Pathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis (2020) (15)
Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment (2018) (15)
Effect of Fcγ-receptor 3a (FCGR3A) gene polymorphisms on rituximab therapy in Hungarian patients with rheumatoid arthritis (2017) (15)
Coexistence of ankylosing spondylitis and rheumatoid arthritis in a female patient (2011) (15)
PECAM-1 and leukosialin (CD43) expression correlate with heightened inflammation in rat adjuvant-induced arthritis. (1999) (15)
Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes. (2020) (15)
Mediators of Angiogenesis (1999) (15)
Expression of bone morphogenetic protein 2, 4, 5, and 7 correlates with histological activity of otosclerotic foci (2012) (14)
Association of HELLP syndrome with primary antiphospholipid syndrome—a case report (2007) (14)
Atherosclerosis in Rheumatoid Arthritis (2012) (14)
Editorial: Comorbidity Burden in Rheumatic Diseases (2018) (14)
The Giants (biologicals) against the Pigmies (small molecules), pros and cons of two different approaches to the disease modifying treatment in rheumatoid arthritis. (2019) (14)
Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective (2014) (14)
A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition (2021) (14)
Assessment of cognitive function in female rheumatoid arthritis patients: associations with cerebrovascular pathology, depression and anxiety (2019) (14)
Treatment of ankylosing spondylitis with biologics and targeted physical therapy (2013) (13)
Mechanisms of Inflammatory Atherosclerosis in Rheumatoid Arthritis (2016) (13)
Technique of synovial biopsy of metacarpophalangeal joints using the needle arthroscope (2002) (13)
Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data (2017) (13)
Impaired endothelial function in patients with undifferentiated connective tissue disease: a follow-up study. (2014) (13)
Characterization and Localization of Citrullinated Proteoglycan Aggrecan in Human Articular Cartilage (2016) (13)
Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider (2018) (13)
[Current aspects of the pathogenesis and clinical characteristics of otosclerosis: possibilities of drug therapy]. (1999) (13)
Visualization of DAS28, SDAI, and CDAI: the magic carpets of rheumatoid arthritis (2014) (13)
Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study) (2022) (12)
Vitamin D status in men with psoriatic arthritis: a case-control study (2015) (12)
Membrane array and multiplex bead analysis of tear cytokines in systemic sclerosis (2016) (12)
Immune-Regulatory Mechanisms in Systemic Autoimmune and Rheumatic Diseases (2012) (12)
Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis (2017) (12)
Ex Vivo Soft-Laser Treatment Inhibits the Synovial Expression of Vimentin and α-Enolase, Potential Autoantigens in Rheumatoid Arthritis (2011) (12)
BTK gene mutation in two non-identical twins with X-linked agammaglobulinemia associated with polyarticular juvenile idiopathic arthritis. (2011) (12)
[Impact of disease progression on health status, quality of life and costs in rheumatoid arthritis in Hungary]. (2008) (12)
Non-MHC Risk Alleles in Rheumatoid Arthritis and in the Syntenic Chromosome Regions of Corresponding Animal Models (2012) (11)
Effects of laser treatment on the expression of cytosolic proteins in the synovium of patients with osteoarthritis (2014) (11)
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance (2022) (11)
Disease activity after the discontinuation of biological therapy in inflammatory rheumatic diseases (2014) (11)
Vasculogenesis in rheumatoid arthritis (2010) (11)
VEGF as an activity marker in rheumatoid arthritis (2010) (11)
Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls (2017) (10)
Assessment of cervical spine involvement in rheumatoid arthritis patients in the era of biologics: a real-life, cross-sectional MRI study (2020) (10)
In Vivo Calcium and Phosphate Iontophoresis for the Topical Treatment of Osteoporosis (2011) (10)
Nephritogenicity of anti-proteoglycan antibodies in experimental murine lupus nephritis. (1992) (10)
Corneal Manifestations of Systemic Sclerosis (2018) (10)
Combination of IgG N‐glycomics and corresponding transcriptomics data to identify anti‐TNF‐α treatment responders in inflammatory diseases (2015) (10)
[Rituximab in patients with rheumatoid arthritis: systematic review]. (2007) (10)
Associations of HLA-shared epitope, anti-citrullinated peptide antibodies and lifestyle-related factors in Hungarian patients with rheumatoid arthritis: data from the first Central-Eastern European cohort. (2011) (10)
Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases (2022) (10)
Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study (2022) (9)
Occurrence of pulmonary rheumatoid nodules following biological therapies (2015) (9)
Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients (2019) (9)
Tocilizumab Treatment in Polyarteritis Nodosa. (2019) (8)
Clinical and immunoserological characteristics of the transition from primary to overlap antiphospholipid syndrome (2010) (8)
Catastrophic antiphospholipid syndrome (Asherson's syndrome) associated with cytokeratin 7-positive endometrial cancer. (2007) (8)
A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis (2019) (8)
Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis (2019) (8)
Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis. (2019) (7)
Changes of Metabolic Biomarker Levels upon One-Year Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis: Associations with Vascular Pathophysiology (2021) (6)
Chemokines and cytokines in inflammatory angiogenesis (2008) (6)
Successful Etanercept Treatment for Primary Biliary Cirrhosis Associated with Rheumatoid Arthritis. (2015) (6)
Capsular neuronal elements and their relation to pain reduction and functional improvement following total hip replacement (2004) (6)
Long-Term Efficacy of Tumor Necrosis Factor Inhibitors for the Treatment of Methotrexate-Naïve Rheumatoid Arthritis: Systematic Literature Review and Meta-Analysis (2019) (6)
Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force (2022) (6)
Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study (2021) (6)
Biosimilars vs originators: Are they the same? (2019) (6)
Upadacitinib versus placebo or adalimumab with background methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate: a subgroup analysis of a phase III randomized controlled trial in Central and Eastern European patients (2020) (6)
POS0239 RISK OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AGED ≥50 YEARS WITH ≥1 CARDIOVASCULAR RISK FACTOR: RESULTS FROM A PHASE 3b/4 RANDOMISED STUDY OF TOFACITINIB VS TUMOUR NECROSIS FACTOR INHIBITORS (2022) (6)
Tumour necrosis factor-α and adenosine in endotoxin shockleading related cardiovascular symptoms (1995) (6)
Lymphocyte adhesion to high endothelium is mediated by two receptors for fibronectin, a^fo and integrin (1992) (6)
[Biological therapy of arthritis and systemic autoimmune diseases]. (2007) (6)
Intercellular adhesion molecule (ICAM)-3 expression on endothelial cells. (1997) (5)
Antiviral and anti-inflammatory therapies in COVID-19 (2021) (5)
[The autoimmune features of vasculopathies]. (2007) (5)
Osteoporosis in mixed connective tissue disease (2003) (5)
[Physiotherapy of cancer patients]. (2016) (5)
Controversies in rheumatism and autoimmunity. (2012) (5)
Rheumatoid arthritis diagnosis with antimutated citrullinated vimentin ELISA by Orgentec Diagnostika. (2008) (5)
Characterization of bone metabolism in hungarian psoriatic arthritis patients: a case–control study (2020) (5)
Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases. (2020) (5)
[Catastrophic antiphospholipid antibody syndrome in a cancer patient]. (1999) (5)
[Cell surface adhesion molecules: structure, function, clinical aspects]. (1992) (4)
Salivary citrullinated proteins in rheumatoid arthritis and associated periodontal disease (2021) (4)
PAR17 BURDEN OF ILLNESS, COSTS AND OUTCOMES OF RHEUMATOID ARTHRITIS IN HUNGARY (2005) (4)
Development of natural calcium- and phosphate-donating microparticles and a new iontophoretic apparatus for the topical treatment of local osteoporosis. Preliminary in vitro and in vivo studies. (2010) (4)
Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency (2022) (4)
Long-term effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow-cytometry for more sensitive assessment of B cell depletion (2012) (4)
Gene expression profiles of systemic lupus erythematosus and rheumatoid arthritis (2007) (4)
COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients (2022) (4)
Thyroid disease and vitamin D deficiency (2010) (4)
Effects of one-year anti-TNF-α therapy on biomarkers of angiogenesis and functional vascular parameters in arthritides (2019) (4)
The effects of breathing exercises in comparison with other exercise programs on cardiorespiratory fitness among healthy female college students. (2019) (4)
THU0580 EULAR TASK FORCE ON GENDER EQUITY IN ACADEMIC RHEUMATOLOGY: PRELIMINARY SURVEY FINDINGS (2020) (4)
Temporal expression of cytokines and chemokines in rat adjuvant-induced arthritis (2001) (3)
[High-dose chemotherapy followed by autologous CD34+ stem cell transplantation in the treatment of severe refractory multisystem autoimmune diseases of adults--first experiences in Hungary]. (2008) (3)
[Vitamin D metabolism and osteoporosis in systemic sclerosis]. (2017) (3)
Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With Dipeptidyl Peptidase-4 Inhibitors: Data of the Post-Hoc Analysis of a Nationwide Study (2021) (3)
Meningitis in mixed connective tissue disease complicated by herpes virus infection: case report (2004) (3)
[Liver resection for a rare parasitic infection--visceral larva migrans syndrome]. (2004) (3)
Biologics use in sle in 23 centers – data from the international registry for biologics in SLE (2011) (3)
POS0519 RELATIONSHIP BETWEEN DISEASE ACTIVITY AND MAJOR ADVERSE EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON TOFACITINIB OR TNF INHIBITORS: A POST HOC ANALYSIS OF ORAL SURVEILLANCE (2022) (3)
FRI0547 Osteoporosis and bone metabolism in systemic sclerosis (2017) (3)
[Why would doctors from Debrecen go abroad? Results of a questionnaire]. (2017) (3)
Effects of tofacitinib therapy on arginine and methionine metabolites in association with vascular pathophysiology in rheumatoid arthritis: A metabolomic approach (2021) (3)
Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients (2021) (3)
Prospective, simultaneous assessment of joint and vascular inflammation by PET/CT in tofacitinib-treated patients with rheumatoid arthritis: associations with vascular and bone status (2021) (3)
Opportunities and challenges in rheumatology research in Central Europe (2017) (3)
A4.3 Effects of anti-TNF therapy on markers of bone homeostasis in rheumatoid arthritis and ankylosing spondylitis (2015) (3)
[Systemic sclerosis and pregnancy. A review of the current literature]. (2014) (3)
Cigarette smoking and clinical response to certolizumab pegol treatment in Hungarian, Czech, and Slovak patients with rheumatoid arthritis: 104-week data from the CIMDORA prospective, non-interventional study. (2019) (3)
POS0237 MAJOR ADVERSE CARDIOVASCULAR EVENTS, MALIGNANCIES AND VENOUS THROMBOEMBOLISM BY BASELINE CARDIOVASCULAR RISK: A POST HOC ANALYSIS OF ORAL SURVEILLANCE (2022) (3)
Cardiac manifestations in a young man with Takayasu arteritis associated with antiphospholipid syndrome. (2012) (3)
Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α Therapy (2020) (3)
[Personalized medicine in rheumatology]. (2013) (2)
PMS18 Impact of Etanercept-Methotrexate Therapy on Patient-Reported Outcomes in Moderately Active Rheumatoid Arthritis (RA) Patients of Europe, Latin America, and Asia (2012) (2)
Effects of Classical Breathing Exercises on Posture, Spinal and Chest Mobility among Female University Students Compared to Currently Popular Training Programs (2022) (2)
Severity and prognostic factors of SARS-CoV-2-induced pneumonia: The value of clinical and laboratory biomarkers and the A-DROP score (2022) (2)
Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn's disease (2013) (2)
[Musculoskeletal relevance of obesity: a new approach to an old topic]. (2019) (2)
AB0329 CERVICAL SPINE INVOLVEMENT IN RHEUMATOID ARTHRITIS (2019) (2)
POS0674 RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS AGED ≥50 YEARS WITH RHEUMATOID ARTHRITIS AND ≥1 ADDITIONAL CARDIOVASCULAR RISK FACTOR: A POST HOC ANALYSIS OF ORAL SURVEILLANCE (2022) (2)
[Cytokines in rheumatoid arthritis: new therapeutic possibilities]. (1998) (2)
[Autoimmune side effects of immune-checkpoint inhibitor therapies in oncology: pathogenesis, clinic and treatment]. (2019) (2)
Etanercept in moderate rheumatoid arthritis: PRESERVE study results from central/eastern Europe, Latin America and Asia (2014) (2)
Effect of pentoxifylline on decreasedin vitro mononuclear leucocyte chemotaxis in vascular and polysystemic autoimmune diseases (1991) (2)
Immunoperoxidase histochemistry for the detection of cellular adhesion molecule, cytokine, and chemokine expression in the arthritic synovium. (2003) (2)
A6.13 Effects of anti-tnf therapy on circulating oxLDL-BETA2GPI complex levels in arthritis (2015) (2)
SAT0687 EVOLVING THE MANAGEMENT OF RHEUMATOID ARTHRITIS THROUGH DEVELOPMENT OF PRACTICAL AND EDUCATIONAL TOOLS (2019) (2)
Anti-neutrophil cytoplasmic antibody testing by indirect immunofluorescence: Computer-aided versus conventional microscopic evaluation of routine diagnostic samples from patients with vasculitis or other inflammatory diseases. (2020) (2)
Development of radiographic classification criteria for hand osteoarthritis: a methodological report (Phase 2) (2022) (2)
OP0264 IMPACT OF BASELINE CARDIOVASCULAR RISK ON THE INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN THE TOFACITINIB RHEUMATOID ARTHRITIS CLINICAL PROGRAMME (2022) (2)
THU0579 “EVOLVING THE MANAGEMENT OF RA” PROGRAMME: EDUCATIONAL TOOLS TO SUPPORT DAILY PRACTICE (2020) (2)
POS0110 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS STRATIFIED BY GEOGRAPHIC REGION AND BASELINE CARDIOVASCULAR RISK: A POST HOC ANALYSIS OF ORAL SURVEILLANCE (2022) (2)
A6.23 Immunological properties of synovial fluid-derived mesenchymal stem cell-like cells in rheumatoid arthritis (2015) (2)
Dr. Szekanecz, et al, reply (2011) (2)
25 – Cell Recruitment and Angiogenesis (2013) (2)
Angiogenesis in Inflammation (2010) (2)
Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients (2021) (2)
Peripheral Lymphocyte Multidrug Resistance Activity as a Predictive Tool of Biological Therapeutic Response in Rheumatoid Arthritis (2019) (2)
Booster Vaccination Decreases 28-Day All-Cause Mortality of the Elderly Hospitalized Due to SARS-CoV-2 Delta Variant (2022) (2)
AB0024 Genetic Signatures May Be Associated with Vascular Pathology in Rheumatoid Arthritis (2015) (1)
A1.83 Long-term effects of etanercept and certolizumab pegol treatment on vascular function and lipid parameters in rheumatoid arthritis and ankylosing spondylitis (2014) (1)
Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database (2019) (1)
THU0399 Effects of 12-Month Etanercept Therapy on Disease Activity, Bone Turnover Markers and Peripheral QCT Bone Mineral Density in Patients with Ankylosing Spondylitis (2013) (1)
Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection? (2022) (1)
AB0606 Effects of 12-month etanercept or certolizumab pegol therapy on disease activity, bone turnover markers and peripheral qct bone mineral density in patients with rheumatoid arthritis (2013) (1)
Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors (2022) (1)
Remarkable international variability in reasons for ineligibility and non-participation in the GLORIA trial (2019) (1)
Angiogenesis in Inflammatory Arthritis. (2019) (1)
[Applicability of laser-based geological techniques in bone research: analysis of calcium oxide distribution in thin-cut animal bones]. (2014) (1)
Safety and efficacy of etanercept therapy in ankylosing spondylitis patients undergoing phacoemulsification surgery. (2010) (1)
Anti-Inflammatory Therapeutic Approaches (2012) (1)
P520 Thromboembolic and major adverse cardiovascular events among patients in the filgotinib clinical trial programme (2023) (1)
FRI0122 Long-term effects of etanercept and certolizumab pegol treatment on vascular function and lipid parameters in rheumatoid arthritis (2013) (1)
THU0642 EULAR POINTS TO CONSIDER FOR THE DEVELOPMENT, EVALUATION AND IMPLEMENTATION OF MOBILE HEALTH APPLICATIONS FOR SELF-MANAGEMENT IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES (2019) (1)
AB0312 Predictors of Disease Course after The Discontinuation of Biologic Therapy in Rheumatoid Arthritis Patients with Long-Term Remission (2016) (1)
Protein in Rat Adjuvant-Induced Arthritis Neutrophil-Activating Peptide-78-Like The Role of an Epithelial (1999) (1)
AB0551 Long-term effects of etanercept treatment on vascular function and lipid parameters in ankylosing spondylitis (2013) (1)
A6.12 Effects of anti-tnf therapy on markers of angiogenesis and vascular pathology in arthritis: a comparative approach (2015) (1)
THU0240 Rosuvastatin improves impaired endothelial function and lowers high sensitivity CRP in patients with systemic sclerosis – a prospective case-series study (2013) (1)
Angiotensin Converting Enzyme Activity in Anti-TNF-Treated Rheumatoid Arthritis and Ankylosing Spondylitis Patients (2022) (1)
POS0520 ASSOCIATION BETWEEN BASELINE STATIN TREATMENT AND MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF ORAL SURVEILLANCE (2022) (1)
OP0263 FAVORABLE BALANCE OF BENEFIT AND HARM OF LONG-TERM, LOW-DOSE PREDNISOLONE ADDED TO STANDARD TREATMENT IN RHEUMATOID ARTHRITIS PATIENTS AGED 65+: THE PRAGMATIC, MULTICENTER, PLACEBO- CONTROLLED GLORIA TRIAL (2022) (1)
Publisher Correction: Cardiovascular effects of approved drugs for rheumatoid arthritis (2021) (1)
Correction to: Assessment of cervical spine involvement in rheumatoid arthritis patients in the era of biologics: a real-life, cross-sectional MRI study (2020) (1)
OP0269 BIOMARKERS TO PREDICT RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TOFACITINIB OR TUMOUR NECROSIS FACTOR INHIBITORS (2022) (1)
SAT0190 Long-Term Follow-Up of 280 Patients with Mixed Connective Tissue Disease (2013) (1)
Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools. (2020) (1)
[Adalimumab in advanced and early rheumatoid arthritis]. (2009) (1)
Mixed connective tissue disease: should the diagnosis be more restrictive?: reply (2005) (1)
SP0126 The vessel wall in imids – new emerging vascular markers (2017) (1)
Successful Treatment of CINCA/NOMID Syndrome with Interleukin-1 Blockade. (2015) (1)
FRI0602 Eular ‘points to consider’ for the conduction of workforce requirement studies in rheumatology (2018) (1)
A6.15 Genetic signatures may be associated with vascular pathology in rheumatoid arthritis (2015) (1)
Successful Treatment of Rheumatoid Arthritis-Associated Renal AA Amyloidosis with Tocilizumab. (2020) (1)
Balneotherapy, a Complementary Non-pharmacological Approach for Non-Inflammatory Complaints in Systemic Lupus Erythematosus: A Pilot Study (2022) (1)
Mediators of Angiogenesis: The Role of Cellular Adhesion Molecules* (2009) (1)
[Angiotensin and its mediators. Their pathogenic and clinical significance in "angiogenic diseases"]. (1998) (1)
Increased frequency of temporal acoustic window failure in rheumatoid arthritis: a manifestation of altered bone metabolism? (2018) (1)
Rosuvastatin improves impaired endothelial function , lowers high sensitivity C-reactive protein , complement and immuncomplex production in patients with systemic sclerosis : a prospective case-series study (2012) (1)
FRI0144 Analysis of the Association Between Cigarette Smoking and Clinical Response to Certolizumab Pegol Treatment in Hungarian Patients with Rheumatoid Arthritis (2015) (1)
Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid Arthritis (2022) (1)
A7.20 Response to Infliximab Therapy can be Predicted using Distinct, Non-Overlapping Gene Panels of Peripheral Blood Gene Expression in Rheumatoid Arthritis and Crohn’s Disease (2013) (1)
Novel clinical and therapeutic aspects in autoimmunity (2017) (1)
Associations of vascular and bone status in arthritis patients (2021) (1)
[Experience with a rheumatoid arthritis biobank: analysis of biological samples and clinical data of 204 patients]. (2017) (1)
Basic (PS01–PS58) (2012) (1)
Biology of Endothelial Cells (2014) (1)
93 – Angiogenesis and vasculogenesis in rheumatoid arthritis (2015) (1)
Posterior Reversible Encephalopathy Syndrome (PRES) Associated with Thrombotic Thrombocytopenic Purpura in a Systemic Lupus Erythematosus Patient. (2017) (1)
Reflections on a contemporary European tragedy (2022) (1)
P075 Changes of metabolic biomarker levels upon anti-tnf therapy in rheumatoid arthritis (2018) (0)
SAT0471 EFFECTS OF ONE YEAR TOFACITINIB THERAPY ON BONE DENSITY AND BIOMARKERS OF BONE TURNOVER IN RHEUMATOID ARTHRITIS (2020) (0)
AB1248-HPR The role of patient support programmes in health literacy of patients. results of a 1.5-year-long hungarian study (2017) (0)
OP0230 Multi Drug Resistance (MDR) Protein Activity of Activated T Lymphocytes Is A Predictor of Biological Treatment Response in Rheumatoid Arthritis (2016) (0)
SARS-CoV-2 infection and its prevention in pediatric autoimmune diseases (2022) (0)
AB0042 Natural Autoantibodies Against Citrate Synthase and DNA Topoisomerase I in Patients with Rheumatoid Arthritis and Spondyloarthritis Receiving Anti-TNF-α Therapy (2015) (0)
AB0689 EVALUATION OF CARDIOVASCULAR DETERMINANTS OF DISEASE OUTCOME IN SYSTEMIC SCLEROSIS (2019) (0)
Subject Index Vol. 61, 1993 (1993) (0)
AB1137 USE OF TOCILIZUMAB IN CRITICALLY ILL SARS-COV-2 PATIENTS CARE- PROGNOSTIC FACTORS OF TREATMENT EFFECTIVENESS AND TREATMENT RESULTS (2022) (0)
SAT0497 Follow-up of disease activity in hungarian patients with idiopathic inflammatory myopathy (2018) (0)
POS1410 DEVELOPMENT OF PREDICTION MODELS FOR SENIOR PATIENTS WITH RHEUMATOID ARTHRITIS AND COMORBIDITIES TREATED WITH CHRONIC LOW-DOSE GLUCOCORTICOIDS IN THE GLORIA TRIAL (2022) (0)
P133 Clinical and immunological effects of tofacitinib therapy in rheumatoid arthritis (2019) (0)
Faculty Opinions recommendation of Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease. (2010) (0)
Chemokines in rheumatoid arthritis and the possibilities of antichemokine targeting Chemotactic cytokines, termed chemokines, are involved in leukocyte chemotaxis and migration through the endothelial barrier into the inflamed synovium, a crucial process for the initiation and maintenance of rheumat (2001) (0)
Reply to: Comment on “effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis” by Cure et al. (2020) (0)
FRI0731 Assessing the risk of rapid radiologic progression in hungarian rheumatoid arthritis patients (2017) (0)
Endothelial Dysfunction and Atherosclerosis in Rheumatoid Arthritis: AMultiparametric Analysis Using Imaging Techniques and Laboratory Markers of Inflammation and Autoimmunity (2008) (0)
[Favorable in vitro effect of pentoxifylline on damaged lymphocyte migration in arteriosclerosis obliterans and systemic lupus erythematosus]. (1993) (0)
SAT0476 Impact of etanercept-methotrexate therapy on patient-reported outcomes in a randomized controlled trial in moderately active rheumatoid arthritis patients (2013) (0)
Prolactin and autoimmunity Autorev (2012) (0)
AB0062 ANGIOTENSIN CONVERTING ENZYME ACTIVITY IN ANTI-TNF-TREATED RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS (2022) (0)
Differentially expressed epigenome modifiers, including Aurora kinase A and B, in immune cells of rheumatoid arthritis (2013) (0)
Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids (2022) (0)
AB0009 Genomic signatures may be associated with vascular pathology associated with rheumatoid arthritis (2017) (0)
Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study (2023) (0)
08.09 Effects of anti-tnf therapy on solubile urokinase plasminogen activator receptor (supar) levels in arthritis (2017) (0)
with AS compared to controls, indicating early, subclinical atherosclerosis associated with AS. These data support that carotid ultrasonography is a valuable technique for detection of early, sublinical vascular disease. (2011) (0)
OP0074 A FRAMEWORK OF POTENTIAL INTERVENTIONS TO ACCELERATE GENDER-EQUITABLE CAREER ADVANCEMENT IN ACADEMIC RHEUMATOLOGY (2021) (0)
Chapter 25 – Cell Recruitment and Angiogenesis (2017) (0)
OP0270 TAPERING OF LONG-TERM, LOW-DOSE GLUCOCORTICOIDS IN SENIOR RHEUMATOID ARTHRITIS PATIENTS: FOLLOW-UP OF THE PRAGMATIC, MULTICENTRE, PLACEBO-CONTROLLED GLORIA TRIAL (2022) (0)
Nagy dózisú kemoterápia és autológ CD34+ őssejt-transzplantáció alkalmazása súlyos felnőttkori terápiarefrakter poliszisztémás autoimmun kórképek kezelésében – az első hazai tapasztalatok@@@High dose chemotherapy followed by autologous CD34+ stem cell transplantation in the treatment of severe refra (2008) (0)
AB0023 Combination of Igg N-Glycomics and Corresponding Transcriptomics Data to Identify Anti-Tnf-Alpha Treatment Responders in Rheumatoid Arthritis and Inflammatory Bowel Disease (2015) (0)
A8.13 Natural autoantibodies against citrate synthase and DNA topoisomerase I in patients with rheumatoid arthritis and spondyloarthritis receiving anti-TNF-α therapy (2015) (0)
[Application of immunomodulatory therapeutic antibodies - a new perspective in oncology]. (2016) (0)
Targeting Chemokines and Angiogenesis in Rheumatoid Arthritis (2011) (0)
Editorial: Reviews in rheumatology (2023) (0)
AB0840 Determination of serum levels of and anti-drug antibody production against tnf inhibitors in ankylosing spondylitis: testing may be useful for the assessment of compliance but not that of treatment effectiveness (2018) (0)
Marked diversity of IL23R gene haplotype variants in rheumatoid arthritis comparing with Crohn’s disease and ankylosing spondylitis (2012) (0)
THU0098 Long-term effects of rituximab on B-cell counts and autoantibody production in rheumatoid arthritis: Use of high-sensitivity flow-cytometry for more sensitive assessment of B-cell depletion (2013) (0)
THU0075 Hypoxia Drives Angiogenesis in Inflammatory Arthritis (2013) (0)
AB0012 Genetic Signatures in Rheumatoid Arthritis: Changes upon Anti-TNF Therapy and Association with Response To Biological Treatment (2016) (0)
FOR THE DEGREE OF DOCTOR OF PHILOSOPHY ( PHD ) EFFECTS OF DISEASE-MODIFYING ANTIRHEUMATIC DRUG TREATMENT ON PERIARTICULAR BONE REMODELING IN RHEUMATOID AND PSORIATIC ARTHRITIS (2018) (0)
POS0222 PREDICTORS OF RESPONSE: BASELINE CHARACTERISTICS AND EARLY TREATMENT RESPONSES ASSOCIATED WITH ACHIEVEMENT OF REMISSION AND LOW DISEASE ACTIVITY AMONG UPADACITINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS (2021) (0)
Subtype in Hungarian Patients with Ankylosing Spondylitis Hungarian Population : The rs 27044 Variant Is Associated with HLA-B * 2705 Gene Polymorphisms with Ankylosing Spondylitis in the ARTS 1 Association (2010) (0)
SP0197 Uncommon Comorbidities in Rheumatic Diseases (2015) (0)
P057 Effects of ANTI-TNF therapy on vascular biomarker levels in rheumatoid arthritis (2018) (0)
Correction to: A prospective, longitudinal monocentric study on laser Doppler imaging of microcirculation: comparison with macrovascular pathophysiology and effect of adalimumab treatment in early rheumatoid arthritis (2020) (0)
AB0157 Effects of Anti-TNF Therapy on Markers of Angiogenesis and Vascular Disease in Rheumatoid Arthritis: A Comparative Approach (2014) (0)
The Impact of Drug Metabolism Gene Polymorphisms on Therapeutic Response and Survival in Diffuse Large B-Cell Lymphoma Patients. (2018) (0)
Cardiac Effects of Antirheumatic Drugs (2017) (0)
Combination of peripheral blood gene expression profiles and clinical parameters predicts response to tocilizumab treatment in rheumatoid arthritis (2011) (0)
Evaluation of the Efficacy of BBIBP-CorV Inactivated Vaccine Combined with BNT62b2 mRNA Booster Vaccine (2023) (0)
Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis: 24-week data from the SIMPACT study (2022) (0)
Successful Treatment of Rheumatoid Arthritis-Associated Renal AA Amyloidosis with Tocilizumab. (2020) (0)
FRI0292 Efficacy of A Conjugated Pneumococcus Vaccine in Rheumatoid Arthritis Patients Treated with Etanercept (2014) (0)
Molecular biological approach of osteoporosis and surgical bone substitution (2009) (0)
Vascular and metabolic effects of anti-TNFα biologics in rheumatoid arthritis (2016) (0)
THU0010 Vitamin d and oestrogen receptor polymorphism in rheumatoid arthritis (2001) (0)
Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme (2023) (0)
Diagnosis and treatment of paediatric multisystem inflammatory syndrome (2021) (0)
Pharmacogenetics and pharmacogenomics in rheumatology (2013) (0)
AB0383 Changes of metabolic biomarker levels upon anti-tnf therapy in rheumatoid arthritis patients (2018) (0)
FRI0398 Derailed b cell homeostasis in patients with mixed connective tissue disease (2013) (0)
THU0181 SOLUBLE VASCULAR BIOMARKERS IN RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS: EFFECTS OF ONE-YEAR ANTI-TNF-Α THERAPY (2020) (0)
OP0207 Transmembrane TNF-Alpha Reverse Signaling Leading To TGF-Beta Production Is Selectively Activated by Anti-TNF-Alpha Targeting Molecules (2016) (0)
POS0043 PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY IN THE ASSESSMENT OF BONE MINERAL DENSITY IN ANTI-TNF-TREATED RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS (2021) (0)
Az immuntolerancia vizsgálata autoimmun kórképekben = Investigations on the immune tolerance in autoimmune diseases (2008) (0)
A to Z of Some New Autoimmune Diseases (2019) (0)
[Adalimumab in arthritis psoriatica]. (2009) (0)
Membrane array and multiplex bead analysis of tear cytokines in systemic sclerosis (2015) (0)
POS0390 SIMULTANEOUS ASSESSMENT OF JOINT AND VASCULAR INFLAMMATION BY PET-CT IN TOFACITINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS: A PROSPECTIVE STUDY (2021) (0)
[Recent advances in gout: pathogenesis, diagnosis, comorbidities, treatment]. (2018) (0)
ESTIMATION OF ANTI-OXLDL AUTOANTIBODIES IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ASSOCIATION WITH PREVIOUS STATIN THERAPY: PP.5.131 (2011) (0)
Superior performance of the CCP3.1 test compared to CCP2 and MCV in the rheumatoid factor-negative RA population (2013) (0)
Soluble vascular biomarkers in rheumatoid arthritis and ankylosing spondylitis: effects of one-year anti-TNF-α therapy (2020) (0)
AB0054 Immunological Properties of Synovial Fluid-Derived Mesenchymal Stem Cell-Like Cells in Rheumatoid Arthritis (2015) (0)
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases. (2023) (0)
FRI0373 ASSOCIATIONS OF VASCULAR PATHOPHYSIOLOGY AND BONE METABOLISM IN ANTI-TNF- TREATED RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS PATIENTS (2020) (0)
FRI0057 Effects of anti-tnf therapy on vascular biomarker levels in rheumatoid arthritis (2018) (0)
Analysis of inflammatory leukocyte and endothelial chemotactic activity. (2007) (0)
FRI0631 Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction quality appraisal tool (2018) (0)
SAT0668 Assessment of intracranial vessels and vascular lesions in rheumatoid arthritis. a detailed transcranial doppler, carotid ultrasound and brain mri study (2017) (0)
P173 Complex assessment of bone mineral density, fracture risk, vitamin D status and bone metabolism in hungarian systemic sclerosis patients (2019) (0)
THU0027 Response to Infliximab Therapy can be Predicted Using Distinct, Non-Overlapping Gene Panels of Peripheral Blood Gene Expression in Rheumatoid Arthritis and Crohn’s Disease (2013) (0)
07.02 Genetic signatures in rheumatoid arthritis: changes upon anti-tnf therapy and association with response to biological treatment (2017) (0)
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic, multicenter, placebo-controlled GLORIA trial (2022) (0)
THU0694 Effects of ANTI-TNF therapy on solubile urokinase plasminogen activator receptor (SUPAR) levels in arthritis (2017) (0)
THU0119 Rheumatoid Arthritis and Periodontal Disease: Association between Salivary Citrulline, ACPA Levels and Clinical Presentation (2016) (0)
A156 THYROID DISEASE AND VITAMIN D DEFICIENCY (2010) (0)
Anti-citrullinated protein / peptide autoantibodies ( ACPA ) in rheumatoid arthritis (2009) (0)
SP0165 Cardiovascular Risk in IMIDS (2015) (0)
Thrombospondin-1 in rat adjuvant-induced arthritis (1997) (0)
SAT0346 Simultaneous assessment of bone loss in rheumatoid arthritis using peripheral quantitative CT and DEXA (2013) (0)
AB1402 A double-blind, sham controlled prospective trial on the efficacy of pulsating electromagnetic field therapy in osteoarthritis using a new therapy device magneter FX (2013) (0)
Angiogenesis in Rheumatoid Arthritis : Zoltán Szekanecz University Medical School o f Debrecen, Debrecen, Hungary Alisa E. Koch Northwestern University Medical School and Department o f Veterans' (1999) (0)
Oncorheumatology: relationship between malignancies and musculoskeletal diseases (2020) (0)
CHAPTER 8I – Endothelial Cells and Angiogenesis (2009) (0)
Chemokines and chemokine receptors (2009) (0)
FRI0089 Assessment of cognitive function in rheumatoid arthritis (2018) (0)
AB0364 Remarkable international variability in reasons for non-participation in the gloria trial (2018) (0)
New targets in the treatment of rheumatoid arthritis (2013) (0)
Laser-induced plasma spectroscopy (LIPS): use of a geological tool in assessing bone mineral content (2018) (0)
AB0160 HIGH NUMBER OF CONCOMITANT MEDICATIONS AND COMORBIDITIES AT BASELINE IN THE GLUCOCORTICOID LOW-DOSE OUTCOME IN RHEUMATOID ARTHRITIS (GLORIA) STUDY: AN OLDER POPULATION WITH RHEUMATOID ARTHRITIS (2021) (0)
POS0677 CONSISTENCY IN TIME TO RESPONSE WITH UPADACITINIB AS MONOTHERAPY OR COMBINATION THERAPY AND ACROSS PATIENT POPULATIONS WITH RHEUMATOID ARTHRITIS (2022) (0)
Corrigendum: Editorial: Reviews in rheumatology (2023) (0)
Novel clinical and therapeutic aspects in autoimmunity (2016) (0)
Toll receptorok és tumorantigének rheumatoid arthritisben = Toll-like receptors and tumor antigens in rheumatoid arthritis (2009) (0)
List of Contributors (2019) (0)
Treatment strategies in rheumatoid arthritis (2013) (0)
Thesis for the degree of Doctor of Philosophy (PhD) CARDIOVACULAR AND CEREBROVASCULAR COMORBIDITIES IN RHEUMATOID ARTHRITIS (2018) (0)
POS1402 COST-EFFECTIVENESS AND COST-UTILITY OF ADD-ON, LOW-DOSE PREDNISOLONE IN RA PATIENTS AGED 65+: THE PRAGMATIC, MULTICENTER, PLACEBO-CONTROLLED GLORIA TRIAL (2022) (0)
AB0082 Effects of Anti-Tnf Therapy on Circulating Oxldl-Beta2Gpi Complex Levels in Arthritis (2015) (0)
effects of adalimumab t reatment on v ascular disease associated with e arly rheumatoid arthritis (2011) (0)
Biosimilars: To switch or not to switch – that is the question (2020) (0)
AB0632 Assessment of vegf and other cytokines in the tear of patients with systemic sclerosis (2017) (0)
THU0050 Effects of Anti-TNF Therapy on Markers of Angiogenesis and Vascular Pathology in Arthritis: A Comparative Approach (2015) (0)
THU0196 Disease Course after the Permanent Cessation of Biological Therapy in Inflammatory Rheumatic Diseases (2013) (0)
Temporomandibular Joint Involvement in Mice with Proteoglycan Induced Arthritis and the Role of TSG-6 in Proteoglycan Induced Arthritis (2019) (0)
OP0272 Effects of Anti-TNF Therapy on Markers of Bone Homeostasis in Rheumatoid Arthritis and Ankylosing Spondylitis (2015) (0)
OP0273 Effects of Tumor Necrosis Factor Alpha on Cytokine Secretion of Synovial Fluid-Derived Mesenchymal Stem Cell-like Cells (2016) (0)
Introduction of a Capillary Gel Electrophoresis-Based Workflow for Biotherapeutics Characterization: Size, Charge, and N-Glycosylation Variant Analysis of Bamlanivimab, an Anti-SARS-CoV-2 Product (2022) (0)
P094 Assessment of intracranial vessels and vascular lesions in rheumatoid arthritis. a detailed transcranial doppler, carotid ultrasound and brain MRI study (2017) (0)
Editorial Atherosclerosis in Rheumatoid Arthritis (2012) (0)
2 Expression of bone morphogenetic protein 2 , 4 , 5 , and 7 correlates 3 with histological activity of otosclerosis 4 (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Zoltán Szekanecz?

Zoltán Szekanecz is affiliated with the following schools: